Harbour BioMed Appoints Youchen Chen as CFO
Youchen (YC) Chen Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics...
BioMed
Mainz Biomed Achieves Full Nasdaq Compliance, Secures Market Position
Mainz Biomed (NASDAQ:MYNZ) has successfully regained full compliance with Nasdaq Capital Market listing requirements. The...
Harbour BioMed Appoints Raymond Zheng As Chief Business Officer
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology...
